Amedeo Smart

Free Medical Literature Service

 

Amedeo

Anemia
  Free Subscription

Articles published in
Int J Hematol
    September 2024
  1. SAEIDNIA M, Shadfar F, Sharifi S, Babashahi M, et al
    Skin complications during iron chelation therapy for beta-thalassemia: overview and treatment approach.
    Int J Hematol. 2024;120:271-277.
    >> Share

    May 2024
  2. KOSUGI M, Takezawa R, Shiota S, Tsuchikawa M, et al
    Clinical management of iron deficiency anemia in Japan: iron prescription patterns, treatment effectiveness, and assessments.
    Int J Hematol. 2024 May 28. doi: 10.1007/s12185-024-03801.
    >> Share

    April 2024
  3. WU LS, Luo X, Tan M, Zhang LJ, et al
    Prevalence of thalassemia-carrier couples and fertility risk assessment.
    Int J Hematol. 2024;119:374-382.
    >> Share

    March 2024
  4. SAWADA Y, Sakamoto K, Tsukamura A, Sawai C, et al
    Vitamin B12 deficiency-induced megaloblastic anemia in a pediatric patient with autism spectrum disorder with a chronically unbalanced diet.
    Int J Hematol. 2024 Mar 25. doi: 10.1007/s12185-024-03759.
    >> Share

  5. KOMATSU N, Arita K, Mitsui H, Nemoto T, et al
    Correction: Efficacy and safety of ferric citrate hydrate compared with sodium ferrous citrate in Japanese patients with iron deficiency anemia: a randomized, double-blind, phase 3 non-inferiority study.
    Int J Hematol. 2024 Mar 6. doi: 10.1007/s12185-024-03739.
    >> Share

  6. OBARA N, Usuki K, Hayashi T, Fujii M, et al
    Burden of illness in Japanese patients with paroxysmal nocturnal hemoglobinuria receiving C5 inhibitors.
    Int J Hematol. 2024;119:255-264.
    >> Share

  7. NAKAO S
    Diagnosis of immune pathophysiology in patients with bone marrow failure.
    Int J Hematol. 2024;119:231-239.
    >> Share

    February 2024
  8. SCHEINBERG P
    Progress in medical therapy in aplastic anemia: why it took so long?
    Int J Hematol. 2024 Feb 26. doi: 10.1007/s12185-024-03713.
    >> Share

  9. ONISHI Y
    Aplastic anemia: history and recent developments in diagnosis and treatment.
    Int J Hematol. 2024 Feb 4. doi: 10.1007/s12185-024-03715.
    >> Share

    January 2024
  10. IGUCHI A, Uchiyama T, Fujimori K, Gocho Y, et al
    HLA-haploidentical T-cell receptor alphabetaT/B-cell-depleted stem cell transplantation for Fanconi anemia.
    Int J Hematol. 2024 Jan 16. doi: 10.1007/s12185-023-03703.
    >> Share

  11. KASHIWAGI H, Kuwana M, Murata M, Shimada N, et al
    Reference guide for the diagnosis of adult primary immune thrombocytopenia, 2023 edition.
    Int J Hematol. 2024;119:1-13.
    >> Share

    December 2023
  12. MAKITA S, Ota S, Mishima Y, Usuki K, et al
    Japanese phase Ib study of the oral PI3K-delta and -gamma inhibitor duvelisib in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.
    Int J Hematol. 2023 Dec 27. doi: 10.1007/s12185-023-03689.
    >> Share

  13. ZHENG J, Gao L, Liu H, Xiao P, et al
    Congenital dyserythropoietic anemia type II in a newborn with a novel compound heterozygous mutation in the SEC23B: a case report and review of the literature.
    Int J Hematol. 2023 Dec 21. doi: 10.1007/s12185-023-03676.
    >> Share

  14. MIKI K, Ogasawara R, Sugimura S, Sugita J, et al
    A case of Hodgkin lymphoma-type Richter syndrome presenting as small-intestinal perforation.
    Int J Hematol. 2023;118:766-771.
    >> Share

    October 2023
  15. SHINN LT, Benitez LL, Perissinotti AJ, Reid JH, et al
    Multicenter evaluation of the addition of eltrombopag to immunosuppressive therapy for adults with severe aplastic anemia.
    Int J Hematol. 2023 Oct 26. doi: 10.1007/s12185-023-03670.
    >> Share

  16. FUKATSU M, Hamazaki Y, Sato Y, Koyama D, et al
    A case of cold agglutinin syndrome associated with chronic lymphocytic leukaemia harbouring mutations in CARD11 and KMT2D.
    Int J Hematol. 2023;118:472-476.
    >> Share

  17. NISHIMURA JI, Kawaguchi T, Ito S, Murai H, et al
    Real-world safety profile of eculizumab in patients with paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, or generalized myasthenia gravis: an integrated analysis of post-marketing surveillance in Japan.
    Int J Hematol. 2023;118:419-431.
    >> Share

    September 2023
  18. CHATZIKALIL E, Kattamis A, Diamantopoulos P, Solomou EE, et al
    New-onset aplastic anemia after SARS-CoV-2 vaccination.
    Int J Hematol. 2023 Sep 28. doi: 10.1007/s12185-023-03666.
    >> Share

  19. LI H, Wang J, Wang D, Gan Y, et al
    Ten years' experience in prenatal diagnosis of alpha-thalassemia in a municipal hospital and retrospective analysis of ultrasonic abnormalities.
    Int J Hematol. 2023;118:355-363.
    >> Share

  20. USUKI K, Ikezoe T, Ishiyama K, Kanda Y, et al
    Interim analysis of post-marketing surveillance of ravulizumab for paroxysmal nocturnal hemoglobinuria in Japan.
    Int J Hematol. 2023;118:311-322.
    >> Share

  21. WANG P, Yang S
    Clonal cytopenia of undetermined significance presenting with multiple duplications of chromosome 1q.
    Int J Hematol. 2023;118:307-308.
    >> Share

    July 2023
  22. EDAHIRO Y, Ochiai T, Hashimoto Y, Morishita S, et al
    Clinical characteristics of Japanese patients with myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis.
    Int J Hematol. 2023;118:47-53.
    >> Share

    May 2023
  23. KOBAYASHI M, Mori A, Oda Y, Yokoyama E, et al
    New onset of hypomegakaryocytic thrombocytopenia with the potential for progression to aplastic anemia after BNT162b2 mRNA COVID-19 vaccination.
    Int J Hematol. 2023 May 23:1-6. doi: 10.1007/s12185-023-03618.
    >> Share

    April 2023
  24. SALES RR, Luizon MR
    Effect of haplotypes of functional SNPs related to expression of fetal hemoglobin (HbF) on clinical prognosis of hematological malignancies.
    Int J Hematol. 2023;117:626-627.
    >> Share

  25. YAMANO S, Iguchi A, Ishikawa K, Sakamoto A, et al
    Splenectomy as an effective treatment for macrothrombocytopenia in Takenouchi-Kosaki syndrome.
    Int J Hematol. 2023;117:622-625.
    >> Share

  26. SUZUKI Y, Shiba T
    Chronic cold agglutinin disease after a third COVID-19 mRNA vaccination.
    Int J Hematol. 2023;117:618-621.
    >> Share

    March 2023
  27. YOSHIDA N
    Recent advances in the diagnosis and treatment of pediatric acquired aplastic anemia.
    Int J Hematol. 2023 Mar 3. doi: 10.1007/s12185-023-03564.
    >> Share

  28. KUBO M, Matsumoto M
    Frontiers in pathophysiology and management of thrombotic thrombocytopenic purpura.
    Int J Hematol. 2023;117:331-340.
    >> Share

    February 2023
  29. PIYAJAROENKIJ T, Tantiworawit A, Khikhuntod J, Piriyakhuntorn P, et al
    Alteration of monocyte subsets and their functions in thalassemia patients.
    Int J Hematol. 2023;117:188-197.
    >> Share

    January 2023
  30. KANDA Y, Mori T, Narita A, Wolter KD, et al
    Correction: Efficacy and safety of equine anti-thymocyte immunoglobulin (eATG) in three Japanese patients with moderate to very severe aplastic anemia: a case series.
    Int J Hematol. 2023 Jan 25. doi: 10.1007/s12185-023-03543.
    >> Share

  31. KANDA Y, Usuki K, Inagaki M, Ohta A, et al
    Decision analysis of allogeneic bone marrow transplantation versus immunosuppressive therapy for young adult patients with aplastic anemia.
    Int J Hematol. 2023 Jan 3. doi: 10.1007/s12185-022-03530.
    >> Share

    December 2022
  32. STORB R
    Allogeneic bone marrow transplantation for aplastic anemia.
    Int J Hematol. 2022 Dec 28. doi: 10.1007/s12185-022-03506.
    >> Share

    November 2022
  33. KANDA Y, Mori T, Narita A, Wolter KD, et al
    Efficacy and safety of equine anti-thymocyte immunoglobulin (eATG) in three Japanese patients with moderate to very severe aplastic anemia: a case series.
    Int J Hematol. 2022 Nov 28. doi: 10.1007/s12185-022-03496.
    >> Share

  34. NAKAMURA Y, Mori T, Kako S, Yamazaki H, et al
    Outcome of peripheral blood stem cell transplantation from HLA-identical sibling donors for adult patients with aplastic anemia.
    Int J Hematol. 2022 Nov 15. pii: 10.1007/s12185-022-03487.
    >> Share

  35. KAWABATA H, Tamura T, Tamai S, Fujibayashi A, et al
    Correction to: Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study.
    Int J Hematol. 2022 Nov 8. pii: 10.1007/s12185-022-03485.
    >> Share

  36. MORITA Y, Nannya Y, Ichikawa M, Hanamoto H, et al
    ASXL1 mutations with serum EPO levels predict poor response to darbepoetin alfa in lower-risk MDS: W-JHS MDS01 trial.
    Int J Hematol. 2022;116:659-668.
    >> Share

  37. LEE FW, Lee CY, Hung GY, Tseng MH, et al
    Recurrent microangiopathic hemolysis after recovery from complement-mediated hemolytic uremia syndrome during chemotherapy for a CFH-mutated patient with T-lymphoblastic lymphoma.
    Int J Hematol. 2022;116:812-818.
    >> Share

    September 2022
  38. CHEN CY, Chen TT, Hsieh CY, Lien MY, et al
    Case reports of management of aplastic anemia after COVID-19 vaccination: a single institute experience in Taiwan.
    Int J Hematol. 2022 Sep 4. pii: 10.1007/s12185-022-03445.
    >> Share

    August 2022
  39. CAMASCHELLA C, Pagani A, Silvestri L, Nai A, et al
    The mutual crosstalk between iron and erythropoiesis.
    Int J Hematol. 2022;116:182-191.
    >> Share

  40. MIYAZAKI Y, Kiguchi T, Sato S, Usuki K, et al
    Prospective comparison of 5- and 7-day administration of azacitidine for myelodysplastic syndromes: a JALSG MDS212 trial.
    Int J Hematol. 2022;116:228-238.
    >> Share

    July 2022
  41. KAWABATA H, Tamura T, Tamai S, Takahashi T, et al
    Intravenous ferric derisomaltose for iron-deficiency anemia associated with gastrointestinal diseases: a single-arm, randomized, uncontrolled, open-label study.
    Int J Hematol. 2022 Jul 22. pii: 10.1007/s12185-022-03420.
    >> Share

  42. KAWABATA H, Tamura T, Tamai S, Fujibayashi A, et al
    Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study.
    Int J Hematol. 2022 Jul 6. pii: 10.1007/s12185-022-03401.
    >> Share

  43. KAMURA Y, Sakamoto T, Yokoyama Y, Nishikii H, et al
    Hemolysis induced by SARS-CoV-2 mRNA vaccination in patients with paroxysmal nocturnal hemoglobinuria.
    Int J Hematol. 2022;116:55-59.
    >> Share

  44. SAKAGUCHI H, Yoshida N
    Recent advances in hematopoietic cell transplantation for inherited bone marrow failure syndromes.
    Int J Hematol. 2022;116:16-27.
    >> Share

    June 2022
  45. MURAKAMI D, Matsuda K, Honda A, Masamoto Y, et al
    Severe infections and renal dysfunction during immunosuppressive therapy with cyclosporine A for aplastic anemia.
    Int J Hematol. 2022 Jun 24. pii: 10.1007/s12185-022-03399.
    >> Share

  46. KAWAKAMI F, Kawakami T, Yamane T, Maruyama M, et al
    T cell clonal expansion and STAT3 mutations: a characteristic feature of acquired chronic T cell-mediated pure red cell aplasia.
    Int J Hematol. 2022;115:816-825.
    >> Share

    April 2022
  47. JITPIRASAKUN S, Pooliam J, Sriwichakorn C, Sanpakit K, et al
    Differences in longitudinal growth patterns of children and adolescents with transfusion-dependent hemoglobin E/beta-thalassemia and those achieving successful hematopoietic stem-cell transplantation.
    Int J Hematol. 2022;115:575-584.
    >> Share

  48. IKEZOE T, Noji H, Ueda Y, Kanda Y, et al
    Long-term follow-up of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: post-marketing surveillance in Japan.
    Int J Hematol. 2022;115:470-480.
    >> Share

  49. HAYAMA K, Abe Y, Kamata H, Okina S, et al
    Bone marrow ring sideroblasts in hematological diseases: an analysis of consecutive 1300 samples in a single institution.
    Int J Hematol. 2022;115:508-514.
    >> Share

    March 2022
  50. YOUSSRY I, ElGhamrawy M, Seif H, Balsamo L, et al
    Prevalence and risk factors of cognitive impairment in children with sickle cell disease in Egypt.
    Int J Hematol. 2022;115:399-405.
    >> Share

  51. HIDAKA D, Ogasawara R, Sugimura S, Fujii F, et al
    New-onset Evans syndrome associated with systemic lupus erythematosus after BNT162b2 mRNA COVID-19 vaccination.
    Int J Hematol. 2022;115:424-427.
    >> Share

    February 2022
  52. SAMPAGAR A, Gosavi M, Kedar P, Patel T, et al
    Clinical, laboratory, and mutational profile of children with glucose phosphate isomerase deficiency: a single centre report.
    Int J Hematol. 2022;115:255-262.
    >> Share

    January 2022
  53. ELENGA N, Vantilcke V, Martin E, Cuadro E, et al
    Red blood cell exchange in children with sickle cell disease.
    Int J Hematol. 2022;115:107-113.
    >> Share

    September 2021
  54. WANG Z, Sun W, Chen H, Zhang Y, et al
    Prevalence and molecular spectrum of alpha- and beta-globin gene mutations in Hainan, China.
    Int J Hematol. 2021;114:307-318.
    >> Share

    July 2021
  55. GASIOR KABAT M, Bueno D, Sisinni L, De Paz R, et al
    Selective T-cell depletion targeting CD45RA as a novel approach for HLA-mismatched hematopoietic stem cell transplantation in pediatric nonmalignant hematological diseases.
    Int J Hematol. 2021;114:116-123.
    >> Share

  56. LIU X, Cheng L, He Y, Zhang R, et al
    Eltrombopag restores erythropoiesis in refractory adult acquired pure red cell aplasia.
    Int J Hematol. 2021;114:124-128.
    >> Share

  57. JANOWIAK-MAJERANOWSKA A, Majeranowski A
    Regarding chronic graft-versus-host disease in children and adolescents with thalassemia after hematopoietic stem cell transplantation.
    Int J Hematol. 2021;114:147-148.
    >> Share

    June 2021
  58. YOSHINARI H, Kawahara Y, Niijima H, Oh Y, et al
    Rapid blood cell recovery with immunosuppressive therapy combined with romiplostim in a patient with very severe hepatitis-associated aplastic anemia who underwent liver transplantation.
    Int J Hematol. 2021 Jun 10. pii: 10.1007/s12185-021-03165.
    >> Share

    May 2021
  59. MAHE K, Couturaud F, Kerspern H, Chauveau A, et al
    Evaluation of beta-2 microglobulin, erythropoietin and tobacco use in polycythemic cases.
    Int J Hematol. 2021 May 22. pii: 10.1007/s12185-021-03164.
    >> Share

    April 2021
  60. CHEN S, Guo Z, Ye Y, Yang S, et al
    Compound heterozygosity for two novel mutations of the SEC23B gene in congenital dyserythropoietic anemia type II.
    Int J Hematol. 2021 Apr 29. pii: 10.1007/s12185-021-03155.
    >> Share

  61. NARUKAWA K, Masuda A, Takahashi T
    Marked erythropoietin-induced dysplastic erythropoiesis in a patient with myelodysplastic syndrome.
    Int J Hematol. 2021 Apr 17. pii: 10.1007/s12185-021-03147.
    >> Share

  62. LERTKOVIT O, Anurathapan U, Hongeng S, Thokanit NS, et al
    Chronic graft-versus-host disease in children and adolescents with thalassemia after hematopoietic stem cell transplantation.
    Int J Hematol. 2021;113:556-565.
    >> Share

    March 2021
  63. KOMATSU N, Arita K, Mitsui H, Nemoto T, et al
    Efficacy and safety of ferric citrate hydrate compared with sodium ferrous citrate in Japanese patients with iron deficiency anemia: a randomized, double-blind, phase 3 non-inferiority study.
    Int J Hematol. 2021 Mar 15. pii: 10.1007/s12185-021-03123.
    >> Share

  64. OTSUKA H, Endo Y, Ohtsu H, Inoue S, et al
    Histidine decarboxylase deficiency inhibits NBP-induced extramedullary hematopoiesis by modifying bone marrow and spleen microenvironments.
    Int J Hematol. 2021;113:348-361.
    >> Share

    February 2021
  65. VIVES-CORRONS JL, Krishnevskaya E, Rodriguez IH, Ancochea A, et al
    Characterization of hereditary red blood cell membranopathies using combined targeted next-generation sequencing and osmotic gradient ektacytometry.
    Int J Hematol. 2021;113:163-174.
    >> Share

  66. PINCZES LI, Szabo R, Miltenyi Z, Illes A, et al
    The impact of autoimmune cytopenias on the clinical course and survival of Hodgkin lymphoma.
    Int J Hematol. 2021;113:175-182.
    >> Share

    January 2021
  67. ROSTAMI T, Monzavi SM, Poustchi H, Khoshdel AR, et al
    Analysis of determinant factors of liver fibrosis progression in ex-thalassemic patients.
    Int J Hematol. 2021;113:145-157.
    >> Share

  68. NAKAMURA Y, Takenaka K, Yamazaki H, Onishi Y, et al
    Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with paroxysmal nocturnal hemoglobinuria.
    Int J Hematol. 2021;113:122-127.
    >> Share

    December 2020
  69. SUN Y, Liu C, Jiao T, Xie N, et al
    Decreased LAG3 expression on T effector cells and regulatory T cells in SAA.
    Int J Hematol. 2020;112:757-763.
    >> Share

    October 2020
  70. NAKAYA A, Kohara T, Shibayama H, Onda Y, et al
    Retrospective multi-center study of Adolescent and Young Adult (AYA) Multiple Myeloma in Kansai Myeloma Forum registry.
    Int J Hematol. 2020;112:435-438.
    >> Share

  71. ISHIYAMA K, Nakao S, Usuki K, Yonemura Y, et al
    Results from multinational phase 3 studies of ravulizumab (ALXN1210) versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria: subgroup analysis of Japanese patients.
    Int J Hematol. 2020;112:466-476.
    >> Share

    September 2020
  72. KAMESAKI T, Nishimura JI, Wada H, Yu E, et al
    Demographic characteristics, thromboembolism risk, and treatment patterns for patients with cold agglutinin disease in Japan.
    Int J Hematol. 2020;112:307-315.
    >> Share

    June 2020
  73. HONG J, Ni J, Ruan M, Yang M, et al
    LMP1-specific cytotoxic T cells for the treatment of EBV-related post-transplantation lymphoproliferative disorders.
    Int J Hematol. 2020;111:851-857.
    >> Share

    May 2020
  74. SAKURAI M, Takemoto H, Mori T, Okamoto S, et al
    In vivo expansion of functional human hematopoietic stem progenitor cells by butyzamide.
    Int J Hematol. 2020;111:739-741.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016